Translate page

English English
en Englishbg Bulgarianzh-CN Chinese (Simplified)hr Croatiancs Czechda Danishnl Dutchfi Finnishfr Frenchde Germanel Greekiw Hebrewhi Hindiid Indonesianit Italianja Japaneseko Koreanmk Macedonianpl Polishpt Portuguesero Romanianru Russiansr Serbiansk Slovaksl Slovenianes Spanishsv Swedishth Thaitr Turkishvi Vietnamese

iCMLf Conversation: CML Highlights of EHA 2023 - Clinical and biological overview

Collage Hochhaus Ong Kopie

Experts:

Professor Andreas Hochhaus
Director of the Department of Hematology and Medical Oncology
Jena University Hospital (Germany)

Professor Tiong S Ong
Duke-NUS Medical School (Singapore) &
Duke University Medical Center, NC (USA) 

Meet-the-CML-Experts Q&A Session: TKI toxicities + dose optimisation

Collage HughesLipton

Panel of experts:

Professor Timothy Hughes
SAHMRI/University of Adelaide/
Royal Hospital of Adelaide (Australia)

Professor Jeff Lipton
University of Toronto (Canada)

iCMLf Conversation: Genomics and Mutations in CML

  susan branford

Expert:

Professor Susan Branford
Head, Leukemia Unit, Genetis and Molecular Pathology, SA Pathology, Adelaide (Australia)

iCMLf Conversation: Management of advanced phases of CML

  Mhairi Copland

Expert:

Professor Mhairi Copland
Professor of Translational Haematology
University of Glasgow
(UK)

iCMLf Conversation: CML Highlights of ASH 2022 - Clinical overview

Michael Mauro

Expert:

Professor Michael Mauro
Leader of the Myeloproliferative Neoplams Program at the Memorial Sloan Kettering Cancer Centre / Professor of Clinical Medicine at the Weill Cornell Medical College, New York (USA)